Artificial Tears Demand Soars As Dry Eye Disease Prevalence Increases: A Key Factor Shaping the Future of the Artificial Tears Market in 2025

What combination of drivers is leading to accelerated growth in the artificial tears market?
The growth of the artificial tear market is anticipated to accelerate due to the increasing occurrence of dry eye disease. This ailment is characterized by eyes not producing a sufficient amount of tears or producing tears of low quality, resulting in discomfort and irritation. Artificial tears help to augment natural tear production, offering relief for dry eyes. For example, a survey in March 2022, conducted by Macquarie University, a public research university in Australia, revealed that out of 5,000 participants, 13% (15 out of 120) aged 50 and above exhibited clinical symptoms of dry eye disease (DED) graded as 8.2% mild, 2.5% moderate, and 1.6% severe. Moreover, data from Eyes On Eyecare, a digital ophthalmology news source based in the US, indicated in March 2022 that the application of prescription and in-office treatments for dry eye disease climbed from 5.8% in 2021 to 7.56% in 2022, with the use of prescription treatments such as topical steroids notably escalating from 0.9% to 9.1% during the same span. Consequently, the escalating occurrence of dry eye disease is fuelling the expansion of the artificial tear market.

Get Your Artificial Tears Market Report Here:
https://www.thebusinessresearchcompany.com/report/artificial-tears-global-market-report

What is the projected compound annual growth rate (CAGR) of the artificial tears market from 2025 to 2034, and what factors influence it?
In recent times, the artificial tears market has experienced significant growth. This market is projected to increase from a value of $3.55 billion in 2024 to reach $3.78 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.5%. The factors driving this growth during the past years include an aging population, extended screen exposure, healthcare spending, the transition from prescription to over-the-counter treatment, and regulatory modifications.

Expectations are high for a robust expansion in the artificial tears market size in the upcoming years. The market is predicted to reach $4.86 billion by 2029, with a compound annual growth rate (CAGR) of 6.5%. This projected growth within the forecast period is reasoned to be due to the rising cases of dry eye syndrome, increase in the use of contact lenses, global urbanization, escalating pollution, and the growth of e-commerce. Future trends within the forecast period include technological developments, the integration of AI and technology, collaborations with healthcare providers, the inclusion of natural ingredients, innovations in product formulation, advanced drug delivery systems, and products that are sustainable and environmentally friendly.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13799&type=smp

What new trends are reshaping the artificial tears market and its opportunities?
Prominent players in the artificial tears market are constantly innovating and incorporating advanced technologies like the patented pureflow technology in their products to increase user safety and convenience. The patented pureflow technology is a unique delivery system designed to offer sterile distribution of preservative-free eye drops, ensuring no contamination and preserving the product's overall integrity. An apt example is Alcon Inc., a medical device and pharmaceutical enterprise based in Switzerland, which launched Systane Complete Preservative-Free Lubricant Eye Drops in January 2022. These next-gen artificial tears are tailored to alleviate symptoms related to all significant kinds of dry eye disorders, including evaporative dry eye and aqueous tear deficiency. Being a preservative-free solution, they offer up to eight hours of sustained relief by moisturizing and safeguarding every layer of the tear film. They employ nano-droplet technology to provide instant hydration to the eye's surface, curb tear evaporation and deliver swift, soothing comfort. The pureflow technology multi-dose bottle not only ensures safety against contamination but also offers ease of use, making it an ideal option for habitual users and people with sensitive eyes.

What are the major segments of the artificial tears market and their role in driving growth?
The artificial tears market covered in this report is segmented -

1) By Type: Glycerin Tears, Cellulose Tears, Oil-Based Emulsion Tears, Polyethylene Glycol-based Tears, Sodium Hyaluronate Based Artificial Tears, Propylene Glycol-based Tears
2) By Dosage: Suspensions, Solution, Ointment, Emulsion, Gel, Spray
3) By Indication: Dry Eye Syndrome, Allergies, Infections, UV And Blue Light Protection, Contact Lens Moisture Retention, Other Indications
4) By Distribution: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Ophthalmic Stores

Subsegments:
1) By Glycerin Tears: Preserved Glycerin Tears, Preservative-Free Glycerin Tears
2) By Cellulose Tears: Hydroxypropyl Methylcellulose (HPMC) Tears, Carboxymethylcellulose (CMC) Tears
3) By Oil-Based Emulsion Tears: Mineral Oil-based Tears, Castor Oil-based Tears
4) By Polyethylene Glycol-based Tears: PEG 400 Tears, PEG 3350 Tears
5) By Sodium Hyaluronate Based Artificial Tears: Low Molecular Weight Sodium Hyaluronate Tears, High Molecular Weight Sodium Hyaluronate Tears
6) By Propylene Glycol-based Tears: Preserved Propylene Glycol Tears, Preservative-Free Propylene Glycol Tears

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13799

Which regions are key players in the growth of the artificial tears market?
North America was the largest region in the artificial tears market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial tears market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the key firms paving the way for growth in the artificial tears market?
Major companies operating in the artificial tears market report are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Abbott Laboratories, Otsuka Pharmaceutical Co. Ltd., Alcon, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Dr Reddy's Laboratories, Santen Pharmaceutical Co. Ltd., Lupin Limited, Rohto Pharmaceutical Co. Ltd., Prestige Consumer Healthcare Inc., Thea Pharma Inc., OPTIMA pharma GmbH, Sentiss Pharma Pvt. Ltd., VISUfarma B.V., OASIS Medical Inc., Hilco Vision, Similasan Corporation, Eyevance Pharmaceuticals LLC, Nicox S.A., I-MED Pharma Inc., Velocity Pharma LLC

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13799&type=smp

What Is Covered In The Artificial Tears Global Market Report?

• Market Size Forecast: Examine the artificial tears market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the artificial tears market for a structured understanding.
• Key Players Overview: Analyze major players in the artificial tears market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the artificial tears market.
• Segment Contributions: Evaluate how different segments drive overall growth in the artificial tears market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the artificial tears market.
• Industry Challenges: Identify potential risks and obstacles affecting the artificial tears market.
• Competitive Landscape: Review strategic developments in the artificial tears market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.